WCN26-5615 A 6-WEEK TREATMENT WITH SEMAGLUTIDE IMPROVES BOTH KIDNEY DYSFUNCTION AND HEART FAILURE WITH PRESERVED EJECTION FRACTION IN THE SDT FATTY RAT MODEL
20260 citationsJournal Articlegold Open Access
Field-Weighted Citation Impact: 0.00
WCN26-5615 A 6-WEEK TREATMENT WITH SEMAGLUTIDE IMPROVES BOTH KIDNEY DYSFUNCTION AND HEART FAILURE WITH PRESERVED EJECTION FRACTION IN THE SDT FATTY RAT MODEL | Researchclopedia